ロード中...
Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37
BACKGROUND: Chronic hepatitis C virus (HCV) infection leads to life-threatening complications worldwide. Immunomodulation signals the response to virus clearance. The immune-suppressive molecule human leukocyte antigen-G (HLA-G) has been shown to function in inhibiting both innate and adaptive immun...
保存先:
| 出版年: | Med Sci Monit |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
International Scientific Literature, Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915332/ https://ncbi.nlm.nih.gov/pubmed/27112970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.895971 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|